RGNX - Regenxbio - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RGNX is currently covered by 10 analysts with an average price target of $32.6. This is a potential upside of $23.01 (239.94%) from yesterday's end of day stock price of $9.59.

Regenxbio's activity chart (see below) currently has 82 price targets and 106 ratings on display. The stock rating distribution of RGNX is 32% HOLD and 68% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.24% with an average time for these price targets to be met of 91.21 days.

Highest price target for RGNX is $55, Lowest price target is $18, average price target is $32.6.

Most recent stock forecast was given by DANIIL GATAULIN from CHARDAN CAPITAL on 20-Nov-2024. First documented stock forecast 12-Oct-2015.

Currently out of the existing stock ratings of RGNX, 8 are a HOLD (32%), 17 are a BUY (68%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$52

$42.41 (442.23%)

$52

3 days ago
(20-Nov-2024)

0/8 (0%)

$42.44 (443.93%)

Buy

$22

$12.41 (129.41%)

8 days ago
(15-Nov-2024)

1/3 (33.33%)

$12.06 (121.33%)

47

Buy

$18

$8.41 (87.70%)

$45

1 months 13 days ago
(10-Oct-2024)

0/5 (0%)

$8.71 (93.76%)

Buy

$55

$45.41 (473.51%)

8 months 16 days ago
(07-Mar-2024)

2/7 (28.57%)

$31.77 (136.76%)

74

Hold

$21

$11.41 (118.98%)

$21

8 months 26 days ago
(28-Feb-2024)

4/4 (100%)

$1.1 (5.53%)

44

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RGNX (Regenxbio) average time for price targets to be met?

On average it took 91.21 days on average for the stock forecasts to be realized with a an average price target met ratio 33.24

Which analyst has the current highest performing score on RGNX (Regenxbio) with a proven track record?

JOSH SCHIMMER

Which analyst has the most public recommendations on RGNX (Regenxbio)?

Josh Schimmer works at CANTOR FITZGERALD and has 3 price targets and 2 ratings on RGNX

Which analyst is the currently most bullish on RGNX (Regenxbio)?

Geulah Livshits with highest potential upside - $73.54

Which analyst is the currently most reserved on RGNX (Regenxbio)?

Gbola Amusa with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?